Epilepsy and Malabsorption

Summary:

Malabsorption is found among people with Epilepsy, especially for people who are female, 60+ old.

The study analyzes which people have Malabsorption with Epilepsy. It is created by eHealthMe based on reports of 35 people who have Epilepsy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Epilepsy?

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures) is found to be associated with 1,163 drugs and 1,776 conditions by eHealthMe. Check the latest studies of Epilepsy.

What is Malabsorption?

Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract) is found to be associated with 639 drugs and 1,100 conditions by eHealthMe. Check the latest studies of Malabsorption.

On Jul, 11, 2026

35 people who have Epilepsy and Malabsorption are studied.

Would you have Malabsorption when you have Epilepsy?

Gender of people who have Epilepsy and experienced Malabsorption *:

female: 54.55 %
male: 45.45 %

Age of people who have Epilepsy and experienced Malabsorption *:

Common co-existing conditions for these people *:

Weight Loss: 3 people, 8.57%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 5.71%
Osteoporosis (bones weak and more likely to break): 2 people, 5.71%
Infantile Spasms: 1 person, 2.86%
Constipation: 1 person, 2.86%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 2.86%
Depression: 1 person, 2.86%
Gastric Ulcer (stomach ulcer): 1 person, 2.86%
Gastritis (inflammation of stomach): 1 person, 2.86%
High Blood Cholesterol: 1 person, 2.86%

Common drugs taken by these people *:

Lamotrigine: 8 people, 22.86%
Phenytoin: 5 people, 14.29%
Keppra: 5 people, 14.29%
Levetiracetam: 5 people, 14.29%
Xenical: 4 people, 11.43%
Dilantin: 3 people, 8.57%
Epidiolex: 3 people, 8.57%
Tegretol: 3 people, 8.57%
Benazepril Hydrochloride: 2 people, 5.71%
Carbamazepine: 2 people, 5.71%

Common symptoms for these people *:

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 14 people, 40.00%
Diarrhea: 8 people, 22.86%
Anticonvulsant Drug Level Decreased: 7 people, 20.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 17.14%
Drug Ineffective: 6 people, 17.14%
Gastrointestinal Infection (infection of stomach and intestine): 4 people, 11.43%
Irritability: 3 people, 8.57%
Weight Decreased: 3 people, 8.57%
Drowsiness: 3 people, 8.57%
Ischaemic Stroke (stroke; caused by an interruption in the flow of blood to the brain): 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Malabsorption?

- Check whether Malabsorption is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Epilepsy (129,285 reports)
Malabsorption (8,910 reports)

All the drugs that are associated with Malabsorption:

Malabsorption (639 drugs)

All the conditions that are associated with Malabsorption:

Malabsorption (1,100 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Malabsorption and Epilepsy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.